Breakthrough T1D Invites Guests to Join the Fight Against T1D at this Year’s One Dream Gala
in Fundraising
WHO: JDRF, the leading global organization focused on type 1 diabetes (T1D) research.
- Chairs: Ruthi Byrne and Robert C. Garrett
- Sponsors: Novo Nordisk, BD, Open Road Auto Group, Hackensack Meridian Health
WHAT: The Breakthrough T1D New Jersey Metro & Rockland County Chapter will host their annual One Dream Gala on Saturday, May 16 at Moorland Farm, Home of the Far Hills Race Meeting. This premiere black-tie optional event will be attended by more than 600 guests, representing some of our state’s leading business, civic, and cultural leaders. This year’s event will feature a seated dinner, silent and live auctions, and amazing entertainment sure to keep guests dancing the night away. There will also be an opportunity to make a direct impact on the lives of people living with T1D through a 100% tax-deductible donation during the Fund A Cure portion of the evening. Last year’s annual gala was no small fête, raising a record-breaking $1.5 million for type 1 diabetes (T1D) research and local community initiatives. As Breakthrough T1D’s community grows each year, so does their determination to find a cure.
WHEN: Saturday, May 16, 2020
- 5:30 pm VIP Reception (By invitation only)
- 6:30 pm Cocktail Reception, Silent Auction, and Golden Ticket Raffle
- 7:30 pm Dinner, Live Auction, Fund A Cure, and Dancing
WHERE: Moorland Farm, Home of the Far Hills Race Meeting
- 50 US 202, Far Hills, NJ 07931
TICKETS: Individual tickets can be purchased for $500, and sponsorship packages can be purchased for $5,000 – $100,000 at https://njmetrorockland.ejoinme.org/OneDreamGala2020.
WHAT ELSE: Breakthrough T1D is the leading global organization focused on type 1 diabetes (T1D) research. Breakthrough T1D’s goal is to progressively remove the impact of diabetes from people’s lives until we achieve a world without T1D. Breakthrough T1D collaborates with a wide spectrum of partners and is the only organization with the scientific resources, regulatory influence and a working plan to bring life-changing therapies from the lab to the T1D community. For more information, visit https://www.breakthrought1d.org/NewJerseyMetro or follow on Facebook, @JDRFNJMetro.
###